- Home
- Articles
- Finance & Economics
- 2025
- August
Finance & Economics News
Jersey City Parks Receive Grants For Safety And Green Space Improvements
Three well-known parks in Jersey City will soon see major improvements after being awarded grants through Hudson County’s Open Space Trust Fund. The funding will bring a range of enhancements to Caven Point, the Bayfront Promenade, and Arlington Park, providing residents with upgraded green spaces, safer recreational areas, and modernized playground facilities. The grants highlight a continued commitment to ensuring that public parks remain vibrant, acces
Jersey City Parks Receive Grants For Safety And Green Space Improvements
Three well-known parks in Jersey City will soon see major improvements after being awarded grants through Hudson County’s Open Space Trust Fund. The funding will bring a range of enhancements to Caven Point, the Bayfront Promenade, and Arlington Park, providing residents with upgraded green spaces, safer recreational areas, and modernized playground facilities. The grants highlight a continued commitment to ensuring that public parks remain vibrant, acces
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp
Novo Nordisk cuts Ozempic price to $499 for uninsured diabetes patients
Novo Nordisk has announced a major price cut for its popular diabetes medication Ozempic, offering the drug for just $499 per month for patients in the United States who are uninsured or paying out-of-pocket. This move represents a significant reduction from the previous list price of nearly $1,350, and it is aimed at improving access for patients who otherwise struggle to afford the medication. The drug will now be available at the lower price through the comp







